Target intelligence / Profile preview

Forty-Two-Three Domain Containing 1 Pseudogene 1 (FYTTD1P1)

Target
FYTTD1P1
Molecular classification
Other (Pseudogene)
01

Overview

**FYTTD1P1 (Forty-Two-Three Domain Containing 1 Pseudogene 1)** is classified as a pseudogene, meaning it resembles a functional gene but contains mutations or alterations that prevent it from producing functional protein[5][1]. Pseudogenes are often considered non-functional DNA elements, although emerging research suggests that some pseudogenes can regulate gene expression at the RNA level in certain contexts, typically by acting as competing endogenous RNAs or through other regulatory mechanisms[2]. However, there is no documented evidence or literature indicating that FYTTD1P1 acts in such a role or is involved in disease, and it is not established as a receptor, enzyme, or any classic therapeutic target. There is no association of FYTTD1P1 with characterized biological function, disease role, or drug targeting in current genetic databases and scientific literature[5][1][4].

Other names
FYTTD1P1Forty-Two-Three Domain Containing 1 Pseudogene 1HGNC:38035NCBI Gene:100128665Ensembl:ENSG00000234502Previous GeneCards IDs: GC00U930822GC09U901612GC09M073735GC09M104135

Beyond the preview

Go deeper on Forty-Two-Three Domain Containing 1 Pseudogene 1 (FYTTD1P1).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Forty-Two-Three Domain Containing 1 Pseudogene 1 (FYTTD1P1).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call